Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

For men with intermediate risk prostate cancer, radiation treatment with brachytherapy alone can result in similar cancer control with fewer long-term side effects, when compared to more aggressive treatment that combines brachytherapy with external beam therapy (EBT), according to research presented today at the 58th Annual Meeting the American Society for Radiation Oncology.

27 Sep 2016

Increasing adoption of SBRT improves survival rates for older patients with early stage lung cancer

Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

27 Sep 2016

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience better quality of life when treated with intensity-modulated radiation therapy (IMRT) than with conventional radiation therapy (RT), according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Study reveals radiosurgery as viable treatment option for patients with resected brain metastases

For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life (QOL), compared to whole brain radiotherapy (WBRT), according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

$Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients$

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

For patients with stage II and III non-small cell lung cancer (NSCLC) unable to receive standard treatments of surgery or chemoradiation (CRT), hypofractionated radiation therapy (RT) results in similar overall survival (OS) and progression-free survival (PFS) rates, limited severe side effects and shorter treatment times when compared to conventional RT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

Stereotactic radiosurgery (SRS) for cancer patients who receive the treatment for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall survival (OS) or distant brain metastases (DBMs) rates, when compared to observation alone following surgical resection of brain metastases, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Researchers identify, validate three distinct molecular subtypes of prostate cancer

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to treatment, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

A new analysis of records in the Veteran's Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with stage I non-small cell lung cancer (NSCLC) in recent years, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

One single genomic fingerprinting could potentially miss smaller, more aggressive prostate tumors

While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal.

22 Sep 2016

Duke researchers discover blood markers linked to drug-resistant tumor cells

While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies.

21 Sep 2016

Study underscores importance of joint treatment decisions between prostate cancer patients and doctors

In light of the findings from the Prostate Testing for Cancer and Treatment trial published yesterday in the New England Journal of Medicine, the American Society for Radiation Oncology would like to congratulate the authors and investigators for conceiving and completing a difficult clinical trial to randomize care for 2,664 men who volunteered to be a part of this study.

16 Sep 2016

HMS scientists reveal how certain tumors develop taste for fat

Cancers are such notorious sugar addicts that PET scans searching for the disease light up when they detect sugar-gobbling tumor cells.

15 Sep 2016

Automated CTC analysis isoflux cytation imager launched by Fluxion Biosciences

Fluxion Biosciences, Inc. announced today that it has launched a new imaging system, the IsoFlux Cytation Imager, designed to work exclusively with the IsoFlux Liquid Biopsy System and CTC Enumeration Kit. The IsoFlux Cytation Imager comes pre-configured with all components and software required for automated CTC image acquisition.

From Fluxion Biosciences 15 Sep 2016

Innovative procedure combining MRI and ultrasound can accurately diagnose prostate cancer

New research confirms that an innovative procedure combining MRI and ultrasound to create a 3D image of the prostate can more accurately locate suspicious areas and help diagnose whether it's prostate cancer.

14 Sep 2016

Using the immune system to fight cancer: an interview with Dr Charles Akle

We all produce as many as 100,000 different types of cancer cells every day, which are recognized and eliminated by our extraordinarily efficient immune system. However, if something goes wrong with the immune system, and it no longer gets rid of these cells, then that’s when cancerous cells grow and become a problem.

12 Sep 2016

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

Increasing adoption of SBRT improves survival rates for older patients with early stage lung cancer

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

Study reveals radiosurgery as viable treatment option for patients with resected brain metastases

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

Researchers identify, validate three distinct molecular subtypes of prostate cancer

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

One single genomic fingerprinting could potentially miss smaller, more aggressive prostate tumors

Duke researchers discover blood markers linked to drug-resistant tumor cells

Study underscores importance of joint treatment decisions between prostate cancer patients and doctors

HMS scientists reveal how certain tumors develop taste for fat

Automated CTC analysis isoflux cytation imager launched by Fluxion Biosciences

Innovative procedure combining MRI and ultrasound can accurately diagnose prostate cancer

Using the immune system to fight cancer: an interview with Dr Charles Akle

Researchers identify how ionising radiation can cause cancer by damaging DNA

Researchers find no increase in cancer risk among WTC-exposed firefighters

Triptolide molecule can turn into 'cruise missile' against cancer

Researchers unlock genetic code that disrupts response to breast cancer therapy

Cedars-Sinai researchers develop new way to identify patients at risk for aggressive prostate cancer

What to know about prostate cancer eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in